Abstract
‘Smart bombs’ were introduced with much fanfare by the US military during the first Gulf War to allay fears about the political consequences of repeating Vietnam-style ‘carpet bombing’. The bombs dropped by the US Air Force, CNN told the world, were so smart that they could find and destroy military installations without causing massive civilian casualties. Like smart bombs, ‘smart’ drugs are supposed to act selectively on particular targets; they are part of a new era of medical treatment, an era characterized by less invasive and less expensive surgery and other ‘targeted’ strategies.
This is an updated and revised version of a paper given at the ‘Risk and Morality’ conference and subsequently published in the resulting collection, Risk and Morality, ed. Richard Ericson. My thanks to Nikolas Rose for sharing his contribution to that collection with me in advance and engaging in conversations that were important both to the conference paper and to this chapter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abrams, D., ‘Transdisciplinary Concepts and Measures of Craving: Commentary and Future Directions’, Addiction, 95 (Supplement 2, 2000): 237–46.
Agosti, V., ‘The efficacy of controlled trials of alcohol misuse treatments in maintaining abstinence: A meta-analysis’, The International Journal of the Addictions, 29, 6 (1994): 759–69.
Amit, Z. and B. R. Smith, ‘Neurotransmitters regulating alcohol intake’, in C. Naranjo and E. Sellers (eds), Novel Pharmacological Interventions for Alcoholism (New York: Springer Verlag, 1990), pp. 161–83.
Anton, R. F., D. Moak, L. R. Waid, P. K. Latham et al., ‘Naltrexone and Cognitive Behavioural Therapy for the Treatment of Outpatient Alcoholics: Results of a Placebo-Controlled Trial’, American Journal of Psychiatry, 156 (1999): 1758–64.
Berg, J. B., J. Volpicelli, D. Herman and C. O’Brien, ‘The Relationship of Alcohol Drinking and Endogenous Opioids: The Opioid Compensation Hypothesis’, in C. Naranjo and E. Sellers (eds), Novel Pharmacological Interventions for Alcoholism (New York: Springer Verlag, 1990), pp. 137–47.
Foucault, M., The Order of Things: An Archeology of the Human Sciences (New York: Vintage, 1973).
Heinala, P., H. Alho, K. Kiianmaa, J. Lonnqvist, K. Kuoppasalmi and J. D. Sinclair, ‘Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: A factorial double-blind, placebo-controlled trial’, Journal of Clinical Psychopharmacology, 21, 3 (2001): 287–92.
Jellinek, E., The Disease Concept of Alcoholism (New Haven, CT: Hillhouse Press, 1960).
Kline, N. S. and T. B. Cooper, ‘Evaluation of Lithium Therapy in Alcoholism’, The Rffects of Centrally Active Drugs on Voluntary Alcohol Consumption (Helsinki, 1975).
Lindstrom, L., Managing Alcoholism: Matching Treatments to Clients (New York and Oxford: Oxford University Press, 1992).
Meyer, R., ‘Craving: What can be done to bring the insights of neuroscience, behavioral science and clinical science into synchrony’, Addiction, 95 (Supplement 2, 2000): 219–27.
Morrison, J., ‘The Government-Voluntary Sector Compacts: Governance, govern- mentality, and civil society’, Journal of Law and Society, 27, 1 (2000): 98–132.
Naranjo, C. and K. E. Bremner (1990), ‘Evaluation of the effects of serotonin uptake inhibitors in alcoholics: A review’, in C. Naranjo and E. Sellers (eds), Novel Pharmacological Interventions for Alcoholism (New York: Springer Verlag, 1990), pp. 105–20.
Naranjo, C., K. E. Bremner and C. X. Poulos, ‘A human model for testing drug-induced concomitant variations in alcohol consumption and the desire to drink’, Novel Pharmacological Interventions for Alcoholism (New York: Springer Verlag, 1990), pp. 288–98.
NIAAA, Press Release: ‘Naltrexone approved for alcoholism treatment’, 17 January (1995). NIAAA Alcohol Alert, 3 July (1996).
NIDA, News Release: ‘Alcohol researchers identify new medication that lessens relapse risk [nalmefene]’, 30 August (1999).
O’Malley, S. et al., ‘Naltrexone in the Treatment of Alcohol Dependence: Preliminary findings’, in C. Naranjo and E. Sellers (eds), Novel Pharmacological Interventions for Alcoholism (New York: Springer Verlag, 1990), pp. 148–59.
O’Malley, S., A. Jaffe, G. Chang, R. Schottenfeld, R. Meyer and B. Rounsaville, ‘Naltrexone and coping skills therapy for alcohol dependence: a controlled study’, Archives of General Psychiatry, 49 (1992): 881–8.
Power, M., ‘The Audit Society’, in A. Hopwood and P. Miller (eds), Accounting as a Social and Institutional Practice (Cambridge: Cambridge University Press, 1994), pp. 299–316.
Rose, N., ‘The Neurochemical Self and its Anomalies’, in R. Ericson (ed.), Risk and Morality (Toronto: University of Toronto Press, 2003), pp. 407–37.
Sinclair, J. D., ‘The effects of lithium on voluntary alcohol consumption by rats’, The Effects of Centrally Active Drugs on Voluntary Alcohol Consumption (Helsinki, 1975).
Sinclair, J. D., ‘New treatment options for substance abuse from a public health point of view’, Ann Med. Of the Finnish Medical Society, 30 (1998): 406–11.
Sinclair, J. D., ‘Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism’, Alcohol and Alcoholism, 36, 1 (2001): 2–10.
Stone, A. A. and S. Shiffman, ‘Ecological Momentary Assessment [EMA]’, Annals of Behavioral Medicine, 16 (1994): 199–203.
Tiffany, S. and C. Conklin, ‘A cognitive processing model of alcohol craving and compulsive alcohol use’, Addiction, 95 (Supplement 2, 2000): 145–53.
Valverde, M., Diseases of the Will: Alcohol and the Dilemmas of Freedom (Cambridge: Cambridge University Press, 1998).
Valverde, M., Law’s Dream of a Common Knowledge (Princeton: Princeton University Press, 2003).
Valverde, M. and M. Mopas, ‘Targeted security’, in W. Larner and W. Walters (eds), Global Governmentality. Governing International Spaces (London: Routledge, 2003), pp. 233–50.
Volpicelli, J., A. Alterman, M. Hayashida and C. O’Brien, ‘Naltrexone in the treatment of alcohol dependence’, Archives of General Psychiatry, 49 (1992): 876–80.
Volpicelli, J., N. Watson, A. King, C. Sherman and C. O’Brien, ‘Effect of naltrexone on alcohol “high” in alcoholics’, American Journal of Psychiatry, 152 (1995): 613–15.
Barber, B. R., Strong Democracy: Participatory Politics for a New Age (Berkeley: University of California Press, 1984/2003).
Donzelot, J., ‘The Promotion of The Social’, Economy and Society, 17, 3 (1988): 395–427.
Ilcan, S. and Basok, T., ‘Community Government: Voluntary Agencies, Social Justice, and the Responsibilization of Citizens’, Citizenship Studies, 8, 2 (2004): 129–44.
Rose, N. and P. Miller, ‘Political Power Beyond the State: Problematics of Government’, The British Journal of Sociology, 41, 2 (1992): 173–205.
Editor information
Editors and Affiliations
Copyright information
© 2007 Mariana Valverde
About this chapter
Cite this chapter
Valverde, M. (2007). ‘Craving’ Research: Smart Drugs and the Elusiveness of Desire. In: Maasen, S., Sutter, B. (eds) On Willing Selves. Palgrave Macmillan, London. https://doi.org/10.1057/9780230592087_8
Download citation
DOI: https://doi.org/10.1057/9780230592087_8
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-28472-6
Online ISBN: 978-0-230-59208-7
eBook Packages: Palgrave Religion & Philosophy CollectionPhilosophy and Religion (R0)